{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T01:45:44Z","timestamp":1771724744157,"version":"3.50.1"},"reference-count":140,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T00:00:00Z","timestamp":1608508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> In premature neonates, the persistence of hemodynamically significant ductus arteriosus (hsPDA) can be associated with short- and long-term consequences, impairing their outcome. The correct strategy of management for such condition is under debate, especially regarding contraindications and\/or side effects. In recent years, metabolomics was applied to several perinatal, pediatric, and adult conditions to investigate potential biomarkers of disease, which have become useful for early diagnosis and\/or therapeutic management.<\/jats:p><jats:p><jats:bold>Aim of the Study:<\/jats:bold> The main purpose of our exploratory study was to asses, through <jats:sup>1<\/jats:sup>H-NMR metabolomics analysis of urinary samples at birth, possible metabolic pathways differentiating, with a significant predictive power, those preterm neonates who will subsequently develop hsPDA and neonates of comparable gestational age (GA) who will undergo spontaneous ductal closure or the persistence of an irrelevant PDA (no-hsPDA). Moreover, we investigated potential prenatal or perinatal clinical factors potentially influencing the development of hsPDA.<\/jats:p><jats:p><jats:bold>Materials and Methods:<\/jats:bold> We enrolled <jats:italic>n<\/jats:italic> = 35 preterm neonates with GA between 24 and 32 weeks; urinary samples were collected within the first 12 h of life. Patients were closely monitored regarding intensive care, respiratory support, fluid balance and administered drugs; an echocardiogram was performed at 48\u201372 h.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Our results reported a significant correlation between lower GA at birth and the development of hsPDA. Moreover, neonates with GA \u2264 30w developing hsPDA were characterized by lower Apgar scores at 1\u2032 and 5\u2032, higher rates of perinatal asphyxia, higher need of delivery room resuscitation and subsequent surfactant administration. Interestingly, metabolomics analysis at birth detected a clear separation between the <jats:sup>1<\/jats:sup>H-NMR urinary spectra of subjects GA \u2264 30w not developing hsPDA (<jats:italic>n<\/jats:italic> = 19) and those of subjects born at GA \u2264 30w in which hsPDA was confirmed at 48\u201372 h of life (<jats:italic>n<\/jats:italic> = 5).<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> This is the first study applying metabolomics to investigate the PDA condition. Although preliminary and conducted on a limited sample, our results reveal that metabolomics could be a promising tool in the early identification of hsPDA, potentially superior to the clinical or laboratory predictive tools explored to date and even to the clinical observations and correlations in our sample, through the detection of specific urinary metabolites.<\/jats:p>","DOI":"10.3389\/fped.2020.613749","type":"journal-article","created":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T07:29:17Z","timestamp":1608535757000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Early Urinary Metabolomics in Patent Ductus Arteriosus Anticipates the Fate: Preliminary Data"],"prefix":"10.3389","volume":"8","author":[{"given":"Flaminia","family":"Bardanzellu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Piras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Atzei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Neroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassilios","family":"Fanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1438038","DOI":"10.1155\/2017\/1438038","article-title":"Paracetamol in patent ductus arteriosus treatment: efficacious and safe?","volume":"2017","author":"Bardanzellu","year":"2017","journal-title":"Biomed Res Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41390-019-0387-7","article-title":"Understanding the pathobiology in patent ductus arteriosus in prematurity-beyond prostaglandins and oxygen","volume":"86","author":"Hundscheid","year":"2019","journal-title":"Pediatr Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3389\/fped.2020.00516","article-title":"Molecular and mechanical mechanisms regulating ductus arteriosus closure in preterm infants","volume":"8","author":"Ovali","year":"2020","journal-title":"Front Pediatr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.pedneo.2017.01.006","article-title":"Influence of platelet count, platelet mass index, and platelet function on the spontaneous closure of ductus arteriosus in the prematurity","volume":"59","author":"Kahvecioglu","year":"2018","journal-title":"Pediatr Neonatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.pedneo.2018.08.006","article-title":"Regarding platelets and ductus: is it platelet function rather than number that matters for ductal closure?","volume":"59","author":"Engur","year":"2018","journal-title":"Pediatr Neonatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0022-3476(96)70356-6","article-title":"Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less","volume":"128","author":"Gonzalez","year":"1996","journal-title":"J Pediatr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e20153730","DOI":"10.1542\/peds.2015-3730","article-title":"Patent ductus arteriosus in preterm infants","volume":"137","author":"Benitz","year":"2016","journal-title":"Pediatrics"},{"key":"B8","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3389\/fped.2020.00541","article-title":"Spontaneous closure of the ductus arteriosus in preterm infants: a systematic review","volume":"8","author":"de Klerk","year":"2020","journal-title":"Front Pediatr"},{"key":"B9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2165\/00002018-200124010-00002","article-title":"NSAID-induced nephrotoxicity from the fetus to the child","volume":"24","author":"Cuzzolin","year":"2001","journal-title":"Drug Saf"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1001\/jama.2018.1896","article-title":"Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants: a systematic review and meta-analysis","volume":"319","author":"Mitra","year":"2018","journal-title":"JAMA"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/NPM-17130","article-title":"Pre-symptomatic targeted treatment of patent ductus arteriosus in preterm newborns: a systematic review and meta-analysis","volume":"12","author":"Farooqui","year":"2019","journal-title":"J Neonatal Perinatal Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"104418","DOI":"10.1016\/j.phrs.2019.104418","article-title":"Efficacy and safety of pharmacological treatments for patent ductus arteriosus closure: a systematic review and network meta-analysis of clinical trials and observational studies","volume":"148","author":"Marconi","year":"2019","journal-title":"Pharmacol Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"CD004213","DOI":"10.1002\/14651858.CD004213.pub4","article-title":"Ibuprofen for the prevention of patent ductus arteriosus in preterm and\/or low birth weight infants","volume":"6","author":"Ohlsson","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"CD010061","DOI":"10.1002\/14651858.CD010061.pub4","article-title":"Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants","volume":"1","author":"Ohlsson","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2020.08.062","article-title":"A randomized placebo-controlled pilot trial of early targeted non-steroidal anti-inflammatory drugs in preterm infants with a patent ductus arteriosus","volume":"25","author":"de Waal","year":"2020","journal-title":"J Pediatr"},{"key":"B16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jpeds.2017.06.054","article-title":"Treatment and nontreatment of the patent ductus arteriosus: identifying their roles in neonatal morbidity","volume":"189","author":"Clyman","year":"2017","journal-title":"J Pediatr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13052-020-0773-0","article-title":"Survey of PDA management in very low birth weight infants across Italy","volume":"46","author":"Ficial","year":"2020","journal-title":"Ital J Pediatr"},{"key":"B18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.earlhumdev.2019.06.002","article-title":"Patent ductus arteriosus in preterm infants born at 23-24 weeks' gestation: should we pay more attention?","volume":"135","author":"Dani","year":"2019","journal-title":"Early Hum Dev"},{"key":"B19","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.siny.2018.02.006","article-title":"Genetics of the patent ductus arteriosus (PDA) and pharmacogenetics of PDA treatment","volume":"23","author":"Lewis","year":"2018","journal-title":"Semin Fetal Neonatal Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41372-018-0285-6","article-title":"Genetic variants associated with patent ductus arteriosus in extremely preterm infants","volume":"39","author":"Dagle","year":"2019","journal-title":"J Perinatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1542\/peds.2008-0313","article-title":"Determination of genetic predisposition to patent ductus arteriosus in preterm infants","volume":"123","author":"Dagle","year":"2009","journal-title":"Pediatrics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.pedneo.2020.03.016","article-title":"Perinatal risk factors of symptomatic preterm patent ductus arteriosus and secondary ligation","volume":"61","author":"Lee","year":"2020","journal-title":"Pediatr Neonatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e0138114","DOI":"10.1371\/journal.pone.0138114","article-title":"Chorioamnionitis and patent ductus arteriosus: a systematic review and meta-analysis","volume":"10","author":"Park","year":"2015","journal-title":"PLoS ONE"},{"key":"B24","doi-asserted-by":"publisher","first-page":"37967","DOI":"10.1038\/srep37967","article-title":"Chorioamnionitis appears not to be a risk factor for patent ductus arteriosus in preterm infants: a systematic review and meta-analysis","volume":"6","author":"Behbodi","year":"2016","journal-title":"Sci Rep"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1080\/14767058.2016.1219991","article-title":"Prevalence and risk factors associated with the patency of ductus arteriosus in premature neonates: a prospective observational study from Iran","volume":"30","author":"Pourarian","year":"2017","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedneo.2020.05.011","article-title":"Differential determinants of patent ductus arteriosus closure for prematurity of varying birth body weight: a retrospective cohort study","volume":"5","author":"Wu","year":"2020","journal-title":"Pediatr Neonatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"H732","DOI":"10.1152\/ajpheart.00838.2013","article-title":"Aminoglycoside-mediated relaxation of the ductus arteriosus in sepsis-associated PDA","volume":"307","author":"Vucovich","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1053\/j.semperi.2010.02.007","article-title":"Inadvertent relaxation of the ductus arteriosus by pharmacologic agents that are commonly used in the neonatal period","volume":"34","author":"Reese","year":"2010","journal-title":"Semin Perinatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3389\/fped.2020.00130","article-title":"Late administration of surfactant may increase the risk of patent ductus arteriosus","volume":"8","author":"Canpolat","year":"2020","journal-title":"Front Pediatr."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14767058.2020.1736028","article-title":"Effects of maternal aspirin treatment on hemodynamically significant patent ductus arteriosus in preterm infants\u2014pilot study","volume":"6","author":"Fridman","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"695","DOI":"10.7326\/M13-2844","article-title":"Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force","volume":"160","author":"Henderson","year":"2014","journal-title":"Ann Intern Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1097\/01.AOG.0000437382.03963.88","article-title":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"B33","volume-title":"WHO Recommendations for Prevention and Treatment of Pre-eclampsia and Eclampsia","year":"2011"},{"key":"B34","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1177\/000992289303201206","article-title":"Severe intracranial hemorrhage in a term neonate associated with maternal acetylsalicylic acid ingestion","volume":"32","author":"Karlowicz","year":"1993","journal-title":"Clin Pediatr (Phila)"},{"key":"B35","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/S0002-9378(94)70056-7","article-title":"Cardiac function in fetuses and newborns exposed to low-dose aspirin during pregnancy","volume":"171","author":"Di Sessa","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e353","DOI":"10.1055\/s-0039-3400316","article-title":"Antenatal magnesium sulfate exposure and hemodynamically significant patent ductus arteriosus in premature infants","volume":"9","author":"Qasim","year":"2019","journal-title":"AJP Rep"},{"key":"B37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.pedneo.2019.05.011","article-title":"Standard-dose gentamicin does not increase risk of patent ductus arteriosus","volume":"61","author":"Kishibuchi","year":"2020","journal-title":"Pediatr Neonatol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jpeds.2018.03.067","article-title":"Association between furosemide exposure and patent ductus arteriosus in hospitalized infants of very low birth weight","volume":"199","author":"Thompson","year":"2018","journal-title":"J Pediatr"},{"key":"B39","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000431281","article-title":"Platelet counts and patent ductus arteriosus in preterm infants: a systematic review and meta-analysis","volume":"108","author":"Simon","year":"2015","journal-title":"Neonatology"},{"key":"B40","first-page":"687","article-title":"Is the first postnatal platelet mass as an indicator of patent ductus arteriosus?","volume":"22","author":"Akar","year":"2019","journal-title":"Arch Iran Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1055\/s-0039-1688821","article-title":"Useful platelet indices for the diagnosis and follow-up of patent ductus arteriosus","volume":"36","author":"Guler Kazanci","year":"2019","journal-title":"Am J Perinatol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1080\/14767058.2018.1536743","article-title":"Is high platelet distribution width in the first hours of life can predict hemodynamically significant patent ductus arteriosus in preterm newborns?","volume":"33","author":"Demirel","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15513815.2019.1686786","article-title":"Utility of the platelet-to-lymphocyte ratio in diagnosing and predicting treatment success in preterm neonates with patent ductus arteriosus","volume":"9","author":"Karabulut","year":"2019","journal-title":"Fetal Pediatr Pathol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"491","DOI":"10.4149\/BLL_2017_094","article-title":"Association between neutrophil\/lymphocyte ratio with ductus arteriosus patency in preterm newborns","volume":"118","author":"Temel","year":"2017","journal-title":"Bratisl Lek Listy"},{"key":"B45","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1017\/S1047951120000943","article-title":"Mature and immature platelets during the first week after birth and incidence of patent ductus arteriosus","volume":"30","author":"Sallmon","year":"2020","journal-title":"Cardiol Young"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e22616","DOI":"10.1002\/jcla.22616","article-title":"A promising, novel index in the diagnosis and follow-up of patent ductus arteriosus: red cell distribution width-to-platelet ratio","volume":"32","author":"\u00d6zer Bekmez","year":"2018","journal-title":"J Clin Lab Anal"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000507553","article-title":"The thromboelastographic profile at birth in very preterm newborns with patent ductus arteriosus","volume":"2","author":"Ghirardello","year":"2020","journal-title":"Neonatology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1055\/s-0039-1678555","article-title":"Does postmenstrual age affect medical patent ductus arteriosus treatment success in preterm infants?","volume":"36","author":"Kaur","year":"2019","journal-title":"Am J Perinatol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/pr.2017.145","article-title":"Polymorphisms in CYP2C9 are associated with response to indomethacin among neonates with patent ductus arteriosus","volume":"82","author":"Smith","year":"2017","journal-title":"Pediatr Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2174\/157339631202160506001309","article-title":"Principles of clinical management of patent ductus arteriosus in extremely preterm neonates","volume":"12","author":"Tan","year":"2016","journal-title":"Curr Pediatr Rev"},{"key":"B51","doi-asserted-by":"publisher","first-page":"676192","DOI":"10.1155\/2013\/676192","article-title":"Patent ductus arteriosus in preterm infants: do we have the right answers?","volume":"2013","author":"Abdel-Hady","year":"2013","journal-title":"Biomed Res Int"},{"key":"B52","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3233\/CH-190803","article-title":"N-terminal pro-brain natriuretic peptide used for screening hemodynamically significant patent ductus arteriosus in very low birth weight infants: how and when?","volume":"75","author":"Liu","year":"2020","journal-title":"Clin Hemorheol Microcirc"},{"key":"B53","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1038\/s41598-020-61291-w","article-title":"Plasma B-type natriuretic peptide cannot predict treatment response to ibuprofen in preterm infants with patent ductus arteriosus","volume":"10","author":"Oh","year":"2020","journal-title":"Sci Rep"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1055\/s-0037-1603509","article-title":"Serum endocan level as a predictive marker for hemodynamically significant patent ductus arteriosus in very low birth weight infants","volume":"34","author":"Halil","year":"2017","journal-title":"Am J Perinatol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41372-018-0123-x","article-title":"Early NT-proBNP levels as a screening tool for the detection of hemodynamically significant patent ductus arteriosus during the first week of life in very low birth weight infants","volume":"38","author":"Rodriguez-Blanco","year":"2018","journal-title":"J Perinatol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00431-018-3089-y","article-title":"Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus","volume":"177","author":"Harris","year":"2018","journal-title":"Eur J Pediatr"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1038\/s41372-018-0192-x","article-title":"High-sensitivity troponin T in preterm infants with a hemodynamically significant patent ductus arteriosus","volume":"38","author":"Asrani","year":"2018","journal-title":"J Perinatol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.anpedi.2016.01.007","article-title":"Utilidad del prop\u00e9ptido natriur\u00e9tico cerebral en el diagn\u00f3stico y manejo del ductus arterioso permeable (Usefulness of brain natriuretic propeptide in the diagnosis and management of patent ductus arteriosus)","volume":"86","author":"Montaner","year":"2017","journal-title":"An Pediatr (Barc)"},{"key":"B59","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3345\/kjp.2017.60.6.175","article-title":"Individualized ibuprofen treatment using serial B-type natriuretic peptide measurement for symptomatic patent ductus arteriosus in very preterm infants","volume":"60","author":"Shin","year":"2017","journal-title":"Korean J Pediatr"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e22664","DOI":"10.1002\/jcla.22664","article-title":"Can lactate levels be used as a marker of patent ductus arteriosus in preterm babies?","volume":"33","author":"Okur","year":"2019","journal-title":"J Clin Lab Anal"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1055\/s-0039-1692389","article-title":"Do calcium and potassium levels influence ductal patency in preterm infants?","volume":"37","author":"Cakir","year":"2020","journal-title":"Am J Perinatol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1055\/s-0038-1673397","article-title":"A mystery of patent ductus arteriosus and serum osmolality in preterm infants","volume":"36","author":"Cakir","year":"2019","journal-title":"Am J Perinatol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13052-019-0706-y","article-title":"Base excess and hematocrit predict response to indomethacin in very low birth weight infants with patent ductus arteriosus","volume":"45","author":"Mydam","year":"2019","journal-title":"Ital J Pediatr"},{"key":"B64","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3109\/14767058.2016.1163684","article-title":"The association of platelets with failed patent ductus arteriosus closure after a primary course of indomethacin or ibuprofen: a systematic review and meta-analysis","volume":"30","author":"Mitra","year":"2017","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fped.2018.00041","article-title":"Association between platelet counts before and during pharmacological therapy for patent ductus arteriosus and treatment failure in preterm infants","volume":"6","author":"Sallmon","year":"2018","journal-title":"Front Pediatr"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e20182565","DOI":"10.1542\/peds.2018-2565","article-title":"Platelet transfusion for PDA closure in preterm infants: a randomized controlled trial","volume":"143","author":"Kumar","year":"2019","journal-title":"Pediatrics"},{"key":"B67","doi-asserted-by":"publisher","first-page":"111","DOI":"10.24875\/ACME.M19000033","article-title":"Correlation of perfusion index with patent ductus arteriosus repercussion in premature newborns","volume":"89","author":"Navarro-Guzm\u00e1n","year":"2019","journal-title":"Arch Cardiol Mex"},{"key":"B68","doi-asserted-by":"publisher","first-page":"6842","DOI":"10.1002\/jcp.27433","article-title":"Altered plasma proteins released from platelets and endothelial cells are associated with human patent ductus arteriosus","volume":"234","author":"Hou","year":"2019","journal-title":"J Cell Physiol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12887-016-0761-0","article-title":"Urinary neutrophil gelatinase-associated lipocalin in the evaluation of patent ductus arteriosus and AKI in very preterm neonates: a cohort study","volume":"17","author":"Sellmer","year":"2017","journal-title":"BMC Pediatr"},{"key":"B70","doi-asserted-by":"publisher","first-page":"F133","DOI":"10.1136\/adc.2010.185967","article-title":"Troponin T, N-terminal pro natriuretic peptide and a patent ductus arteriosus scoring system predict death before discharge or neurodevelopmental outcome at 2 years in preterm infants","volume":"96","author":"El-Khuffash","year":"2011","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"B71","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/jp.2012.86","article-title":"Urinary NT-proBNP and ductal closure in preterm infants","volume":"33","author":"Czernik","year":"2013","journal-title":"J Perinatol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/jp.2017.139","article-title":"Urinary NT-proBNP levels and echocardiographic parameters for patent ductus arteriosus","volume":"37","author":"Khan","year":"2017","journal-title":"J Perinatol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"78","DOI":"10.2174\/157339631202160506001001","article-title":"Editorial: patent ductus arteriosus in extremely premature neonates","volume":"12","author":"Vettukattil","year":"2016","journal-title":"Curr Pediatr Rev"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e510","DOI":"10.1542\/peds.2014-1995","article-title":"Diagnosing significant PDA using natriuretic peptides in preterm neonates: a systematic review","volume":"135","author":"Kulkarni","year":"2015","journal-title":"Pediatrics"},{"key":"B75","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2174\/157339631202160506002028","article-title":"Pharmacotherapy for patent ductus arteriosus: current options and outstanding questions","volume":"12","author":"Rostas","year":"2016","journal-title":"Curr Pediatr Rev"},{"key":"B76","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.rec.2015.09.014","article-title":"Inflammation, high-sensitivity C-reactive protein, and persistent patent ductus arteriosus in preterm infants","volume":"69","author":"Hillman","year":"2016","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"B77","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1080\/09537104.2016.1203398","article-title":"C-reactive protein, platelets, and patent ductus arteriosus","volume":"27","author":"Meinarde","year":"2016","journal-title":"Platelets"},{"key":"B78","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41390-018-0182-x","article-title":"Exploration of potential biochemical markers for persistence of patent ductus arteriosus in preterm infants at 22-27 weeks' gestation","volume":"86","author":"Olsson","year":"2019","journal-title":"Pediatr Res"},{"key":"B79","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1055\/s-0035-1544948","article-title":"Antioxidants and biomarkers of oxidative stress in preterm infants with symptomatic patent ductus arteriosus","volume":"32","author":"Inayat","year":"2015","journal-title":"Am J Perinatol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3389\/fped.2020.00555","article-title":"Isoprostanes as biomarker for patent ductus arteriosus in preterm infants","volume":"8","author":"Coviello","year":"2020","journal-title":"Front Pediatr"},{"key":"B81","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13052-020-0807-7","article-title":"How could metabolomics change pediatric health?","volume":"46","author":"Bardanzellu","year":"2020","journal-title":"Ital J Pediatr"},{"key":"B82","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1159\/000487620","article-title":"Clinical metabolomics in neonatology: from metabolites to diseases","volume":"113","author":"Fanos","year":"2018","journal-title":"Neonatology"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.2174\/1381612811209022996","article-title":"Pharma-metabolomics in neonatology: is it a dream or a fact?","volume":"18","author":"Fanos","year":"2012","journal-title":"Curr Pharm Des"},{"key":"B84","first-page":"p. 111","article-title":"Urinary metabolomics as a new strategy to discriminate response to ibuprofen therapy in preterm neonates with patent ductus arteriosus","volume-title":"Proceedings of the Selected Abstracts of the 8th International Workshop on Neonatology","author":"Castell","year":"2012"},{"key":"B85","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2174\/1573396315666191022102925","article-title":"Pediatric acute-onset neuropsychiatric syndrome and mycoplasma pneumoniae infection: a case report analysis with a metabolomics approach","volume":"16","author":"Piras","year":"2020","journal-title":"Curr Pediatr Rev"},{"key":"B86","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.chemolab.2013.01.006","article-title":"Optimized bucketing for NMR spectra: three case studies","volume":"122","author":"Sousa","year":"2013","journal-title":"Chemometr Intell Lab"},{"key":"B87","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/1471-2164-7-142","article-title":"Centering, scaling, and transformations: improving the biological information content of metabolomics data","volume":"7","author":"van den Berg","year":"2006","journal-title":"BMC Genomics"},{"key":"B88","doi-asserted-by":"publisher","first-page":"5401","DOI":"10.3390\/app10165401","article-title":"Urinary1H-NMR metabolic signature in subjects undergoing colonoscopy for colon cancer diagnosis","volume":"10","author":"Piras","year":"2020","journal-title":"Appl Sci"},{"key":"B89","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.biocel.2017.07.024","article-title":"Metabolomic profile in hyperthyroid patients before and after antithyroid drug treatment: correlation with thyroid hormone and TSH concentration","volume":"93","author":"Piras","year":"2017","journal-title":"Int J Biochem Cell Biol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1021\/ac060209g","article-title":"Targeted profiling: quantitative analysis of 1H NMR metabolomics data","volume":"78","author":"Weljie","year":"2006","journal-title":"Anal Chem"},{"key":"B91","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B (Methodol)"},{"key":"B92","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/1120009X.2007.11782443","article-title":"Therapeutic drug monitoring of gentamicin in neonatal intensive care unit: experience in 68 newborns","volume":"19","author":"Testa","year":"2007","journal-title":"J Chemother"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s00467-019-4194-5","article-title":"Patent ductus arteriosus is associated with acute kidney injury in the preterm infant","volume":"34","author":"Majed","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1080\/14767058.2018.1460349","article-title":"The effect of hemodynamically significant patent ductus arteriosus on acute kidney injury and systemic hypertension in extremely low gestational age newborns","volume":"32","author":"Velazquez","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41372-019-0560-1","article-title":"Echocardiographic predictors of acute kidney injury in neonates with a patent ductus arteriosus","volume":"40","author":"Coffman","year":"2020","journal-title":"J Perinatol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.2174\/092986712803306439","article-title":"Nenatal drug induced nephrotoxicity: old and next generation biomarkers for early detection and management of neonatal drug-induced nephrotoxicity, with special emphasis on uNGAL and on metabolomics","volume":"19","author":"Fanos","year":"2012","journal-title":"Curr Med Chem"},{"key":"B97","doi-asserted-by":"publisher","first-page":"7620671","DOI":"10.1155\/2018\/7620671","article-title":"Urinary 1H-NMR metabolomics in the first week of life can anticipate BPD diagnosis","volume":"2018","author":"Pintus","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"B98","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3109\/14767058.2014.955966","article-title":"Urinary metabolomics of bronchopulmonary dysplasia (BPD): preliminary data at birth suggest it is a congenital disease","volume":"27","author":"Fanos","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B99","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/BF02783480","article-title":"High-resolution proton nuclear magnetic resonance studies of urine from asphyxiated newborn infants","volume":"53","author":"Ma","year":"1995","journal-title":"Appl Biochem Biotechnol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3389\/fnins.2020.00460","article-title":"A novel, multi-faceted perception of lactate in neurology","volume":"14","author":"Mason","year":"2020","journal-title":"Front Neurosci"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1038\/jcbfm.2015.115","article-title":"A probable dual mode of action for both L- and D-lactate neuroprotection in cerebral ischemia","volume":"35","author":"Castillo","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"key":"B102","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fnins.2017.00043","article-title":"Lactate shuttles in neuroenergetics-homeostasis, allostasis and beyond","volume":"11","author":"Mason","year":"2017","journal-title":"Front Neurosci"},{"key":"B103","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3390\/ijms20020282","article-title":"Astrocyte signaling in the neurovascular unit after central nervous system injury","volume":"20","author":"Huang","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B104","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/s41419-019-1877-6","article-title":"Lactate and pyruvate promote oxidative stress resistance through hormetic ROS signaling","volume":"10","author":"Tauffenberger","year":"2019","journal-title":"Cell Death Dis"},{"key":"B105","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1007\/s12035-019-01863-8","article-title":"Lactate: more than merely a metabolic waste product in the inner retina","volume":"57","author":"Vohra","year":"2020","journal-title":"Mol Neurobiol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/j.jmb.2019.03.005","article-title":"Lactate-mediated protection of retinal ganglion cells","volume":"431","author":"Vohra","year":"2019","journal-title":"J Mol Biol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3174\/ajnr.A5505","article-title":"Expression changes in lactate and glucose metabolism and associated transporters in basal ganglia following hypoxicischemic reperfusion injury in piglets","volume":"39","author":"Zheng","year":"2018","journal-title":"Am J Neuroradiol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.eplepsyres.2019.03.007","article-title":"Sustained elevation of cerebrospinal fluid glucose and lactate after a single seizure does not parallel with mitochondria energy production","volume":"152","author":"Oses","year":"2019","journal-title":"Epilepsy Res"},{"key":"B109","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.1021\/acs.jproteome.6b00537","article-title":"Impact of early postnatal nutrition on the NMR urinary metabolic profile of infant","volume":"15","author":"Cesare Marincola","year":"2016","journal-title":"J Proteome Res"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/s41372-020-00799-5","article-title":"Blood myo-inositol concentrations in preterm and term infants","author":"Brion","year":"2020","journal-title":"J Perinatol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3109\/01443615.2013.831046","article-title":"Myoinositol: a new marker of intrauterine growth restriction?","volume":"33","author":"Dess\u00ec","year":"2013","journal-title":"J Obstet Gynaecol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3109\/14767058.2014.955674","article-title":"Investigation of the 1H-NMR based urine metabolomic profiles of IUGR, LGA and AGA newborns on the first day of life","volume":"27","author":"Dess\u00ec","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B113","doi-asserted-by":"publisher","first-page":"CD012048","DOI":"10.1002\/14651858.CD012048.pub2","article-title":"Dietary supplementation with myo-inositol in women during pregnancy for treating gestational diabetes","volume":"9","author":"Brown","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1210\/jc.2004-1513","article-title":"Polyol concentrations in the fluid compartments of the human conceptus during the first trimester of pregnancy: maintenance of redox potential in a low oxygen environment","volume":"90","author":"Jauniaux","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B115","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/bdra.23533","article-title":"Inositol, neural tube closure and the prevention of neural tube defects","volume":"109","author":"Greene","year":"2017","journal-title":"Birth Defects Res"},{"key":"B116","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/eurheartj\/ehu002","article-title":"Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide","volume":"35","author":"Wang","year":"2014","journal-title":"Eur Heart J"},{"key":"B117","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3390\/toxins8110326","article-title":"Trimethylamine N-oxide: the good, the bad and the unknown","volume":"8","author":"Velasquez","year":"2016","journal-title":"Toxins (Basel)"},{"key":"B118","doi-asserted-by":"publisher","first-page":"e02481","DOI":"10.1128\/mBio.02481-14","article-title":"Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide","volume":"6","author":"Romano","year":"2015","journal-title":"mBio"},{"key":"B119","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/ki.1993.37","article-title":"NMR spectroscopy as a novel approach to the monitoring of renal transplant function","volume":"43","author":"Foxall","year":"1993","journal-title":"Kidney Int"},{"key":"B120","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1159\/000187525","article-title":"Proton nuclear magnetic resonance spectroscopy of urine and plasma in renal transplantation follow-up","volume":"65","author":"Le Moyec","year":"1993","journal-title":"Nephron"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1093\/clinchem\/48.7.1106","article-title":"Rhabdomyolysis-related renal tubular damage studied by proton nuclear magnetic resonance spectroscopy of urine","volume":"48","author":"Bairaktari","year":"2002","journal-title":"Clin Chem"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1093\/ndt\/gfh142","article-title":"Evidence for protective roles of polyethylene glycol plus high sodium solution and trimetazidine against consequences of renal medulla ischaemia during cold preservation and reperfusion in a pig kidney model","volume":"19","author":"Faure","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"B123","doi-asserted-by":"publisher","first-page":"F153","DOI":"10.1136\/fn.73.3.F153","article-title":"Analysis of fetal and neonatal urine using proton nuclear magnetic resonance spectroscopy","volume":"73","author":"Foxall","year":"1995","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"B124","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11306-019-1605-3","article-title":"Urinary metabolomics reveals kynurenine pathway perturbation in newborns with transposition of great arteries after surgical repair","volume":"15","author":"Simonato","year":"2019","journal-title":"Metabolomics"},{"key":"B125","doi-asserted-by":"publisher","first-page":"e112945","DOI":"10.1371\/journal.pone.0112945","article-title":"Involvement of the kynurenine pathway in human glioma pathophysiology","volume":"9","author":"Adams","year":"2014","journal-title":"PLoS ONE"},{"key":"B126","doi-asserted-by":"publisher","first-page":"8008","DOI":"10.1038\/s41598-018-25968-7","article-title":"Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-\u03b2 load: a pilot study","volume":"8","author":"Chatterjee","year":"2018","journal-title":"Sci Rep"},{"key":"B127","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.pneurobio.2015.12.009","article-title":"Involvement of the kynurenine pathway in the pathogenesis of Parkinson's disease","volume":"155","author":"Lim","year":"2017","journal-title":"Prog Neurobiol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1002\/aur.1748","article-title":"The urinary 1 H-NMR metabolomics profile of an italian autistic children population and their unaffected siblings","volume":"10","author":"Lussu","year":"2017","journal-title":"Autism Res"},{"key":"B129","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/15438627.2011.608046","article-title":"The effect of muscle actions on the level of connective tissue damage","volume":"19","author":"Nogueira Ade","year":"2011","journal-title":"Res Sports Med"},{"key":"B130","unstructured":"Bethesda, MDNational Library of Medicine; National Center for Biotechnology InformationPubChem Compound Summary for CID 5810, Hydroxyproline2004"},{"key":"B131","unstructured":"Bethesda, MDNational Library of Medicine; National Center for Biotechnology InformationPubChem Compound Summary for CID 79101, Glycylproline2004"},{"key":"B132","unstructured":"Bethesda, MDNational Library of Medicine; National Center for Biotechnology InformationPubChem Compound Summary for CID 70639, 3-Methylxanthine2004"},{"key":"B133","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12934-015-0395-1","article-title":"Direct conversion of theophylline to 3-methylxanthine by metabolically engineered E. coli.","volume":"14","author":"Algharrawi","year":"2015","journal-title":"Microb Cell Fact"},{"key":"B134","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5414\/CPP39053","article-title":"Caffeine metabolism before and after liver transplantation","volume":"39","author":"Bechtel","year":"2001","journal-title":"Int J Clin Pharmacol Ther"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.lfs.2007.07.032","article-title":"Possible involvement of organic anion and cation transporters in renal excretion of xanthine derivatives, 3-methylxanthine and enprofylline","volume":"81","author":"Nadai","year":"2007","journal-title":"Life Sci"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/bcp.13211","article-title":"Prediction of serum theophylline concentrations and cytochrome P450 1A2 activity by analyzing urinary metabolites in preterm infants","volume":"83","author":"Sohn","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3109\/14767058.2014.954786","article-title":"Urinary metabolomics (GC-MS) reveals that low and high birth weight infants share elevated inositol concentrations at birth","volume":"2","author":"Barberini","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B138","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.2741\/306","article-title":"1H NMR-based metabolomic analysis of urine from preterm and term neonates","volume":"3","author":"Atzori","year":"2011","journal-title":"Front Biosci (Elite Ed)"},{"key":"B139","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3109\/14767058.2011.605868","article-title":"Metabolomics in newborns with intrauterine growth retardation (IUGR): urine reveals markers of metabolic syndrome","volume":"2","author":"Dess\u00ec","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B140","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1016\/S0378-3782(14)70024-6","article-title":"Urinary (1)H-NMR and GC-MS metabolomics predicts early and late onset neonatal sepsis","volume":"90","author":"Fanos","year":"2014","journal-title":"Early Hum Dev"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2020.613749\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T07:29:35Z","timestamp":1608535775000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2020.613749\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,21]]},"references-count":140,"alternative-id":["10.3389\/fped.2020.613749"],"URL":"https:\/\/doi.org\/10.3389\/fped.2020.613749","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,21]]},"article-number":"613749"}}